World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
34016
World Ranking
12111
National Ranking
657

Overview

Orhan Sezer is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on Medicine, with significant contributions to Biochemistry, Genetics, and Molecular Biology. Their subfields emphasize Molecular Biology, Hematology, and Oncology.

The scientist's work centers around topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Ubiquitin and Proteasome Pathways, and Cancer Treatment and Pharmacology.

Sezer has authored publications in notable venues including:

  • The Lancet Oncology
  • British Journal of Haematology

Recent papers include:

  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, 2021, The Lancet Oncology
  • Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations, 2021, British Journal of Haematology

The frequent coauthors collaborating with Sezer are:

  • Philippe Moreau
  • Elena Zamagni
  • Artur Jurczyszyn
  • Niels W.C.J. van de Donk
  • Michèle Cavo

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

    Morie A. Gertz;Ray Comenzo;Rodney H. Falk;Jean Paul Fermand

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

    Andreas Engert;Volker Diehl;Jeremy Franklin;Andreas Lohri

  • Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

    Meletios A. Dimopoulos;Evangelos Terpos;Asher Chanan-Khan;Nelson Leung

  • Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.

    J.M Blazeby;T Conroy;E Hammerlid;P Fayers

  • Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)

    Antonio Palumbo;Sara Bringhen;Heinz Ludwig;Meletios A. Dimopoulos

  • International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease

    Evangelos Terpos;Gareth Morgan;Meletios Athanasios Dimopoulos;Matthew T. Drake

  • International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

    M Dimopoulos;E Terpos;R L Comenzo;P Tosi

  • Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

    C. Fernández De Larrea;R. A. Kyle;B. G.M. Durie;H. Ludwig

  • Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2

    Nikhil Munshi;Nikhil Munshi;Kenneth Carl Anderson;Leif Bergsagel;John Shaughnessy

  • Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement

    Meletios A. Dimopoulos;Jens Hillengass;Saad Usmani;Elena Zamagni

  • European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

    Evangelos Terpos;Martina Kleber;Monika Engelhardt;Sonja Zweegman

  • International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

    Michele Cavo;S. Vincent Rajkumar;Antonio Palumbo;Philippe Moreau

  • Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.

    RN Whistance;T Conroy;W Chie;A Costantini

  • RANK ligand and osteoprotegerin in myeloma bone disease

    Orhan Sezer;Ulrike Heider;Ulrike Heider;Ivana Zavrski;Ivana Zavrski;Christian Alexander Kühne;Christian Alexander Kühne

  • Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

Frequent Co-Authors

Hermann Einsele
Hermann Einsele University of Würzburg
Evangelos Terpos
Evangelos Terpos National and Kapodistrian University of Athens
Michele Cavo
Michele Cavo University of Bologna
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Brian G.M. Durie
Brian G.M. Durie Cedars-Sinai Medical Center
Antonio Palumbo
Antonio Palumbo University of Turin
Roman Hájek
Roman Hájek University of Ostrava
Jane M Blazeby
Jane M Blazeby University of Bristol
Paul G. Richardson
Paul G. Richardson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students exploring Medicine in the USA also consider related online pathways, especially in nursing and allied health. Online degrees offer flexibility and can be more budget-friendly compared to traditional routes. A key question to consider is how much is online nursing school? Costs can vary greatly, but online programs are often more affordable, with many options available that fit a range of budgets.

For those looking to advance their nursing qualifications, you can find the cheapest dnp programs online, which are ideal for nurses aiming for leadership roles or academic careers. If you’re an RN seeking to obtain your Bachelor of Science in Nursing, the cheapest rn to bsn program online can help you enhance your credentials quickly and affordably.

Even students without a nursing background have options for entering this field. You can consider direct entry online msn programs designed for non-nurses, which allow career changers to make the transition to nursing roles in a shorter time frame.

Exploring these online degrees broadens your healthcare career options and may be a worthwhile step alongside or as an alternative to a traditional medical degree.

Best Scientists Citing Orhan Sezer

Trending Scientists